Drugs & Targets Veritas Genetics introduces whole genome platform for under $1,000 March 11, 2016Vol.42 No.10
Drugs & Targets NanoString Technologies and Merck to collaborate on Keytruda assay March 04, 2016Vol.42 No.09
Drugs & Targets Merck KGaA, Pfizer and Verastem enter into avelumab research agreement March 04, 2016Vol.42 No.09
Drugs & Targets FDA and EMA grant orphan designations to FLAG-003 for glioma March 04, 2016Vol.42 No.09
Drugs & Targets FDA grants orphan drug designation to SELLAS’s WT1 cancer vaccine March 04, 2016Vol.42 No.09
Drugs & Targets Imbruvica Granted 5th Approval, For First-Line CLL Patients March 04, 2016Vol.42 No.09
Drugs & Targets FDA Approves Gazyva Plus Bendamustine for Patients with Follicular Lymphoma February 29, 2016Vol.39 No.02
Drugs & Targets FDA grants Breakthrough Designation to PKC412 (midostaurin) February 26, 2016Vol.42 No.08
